Literature DB >> 17566610

[Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].

O Decaux1, P Rodon, A Ruelland, L Estepa, R Leblay, B Grosbois.   

Abstract

PURPOSE: Monoclonal gammopathy are common in the general population. We describe biological features and etiology of monoclonal gammopathy diagnosed during more than a ten year period in the Internal Medicine Department of Rennes University Hospital and in all the medical departments of General Hospital of Blois.
METHODS: Patients were identified by immunofixation registry of Biochemistry Laboratories in both hospital (from 1990 in Rennes and from 1980 in Blois).
RESULTS: Internal Medicine Department of Rennes University Hospital: 1051 monoclonal gammapathies were identified: 514 men and 537 women. Median age was 71. Isotypes repartition was: IgG 42.8% (450 cases), IgM 31.9% (335), IgA 8.9% (94) biclonal gammopathy 9.8% (103). Sixty-nine monoclonal light chains (6.6%) were identified. Median concentration of monoclonal protein was 14 g/l (1.8-104.4). All department of General Hospital of Blois: 1282 monoclonal gammapathies were identified: 700 men and 582 women. Median age was 79. Isotypes repartition was: IgG 59.7% (765 cases), IgM 27.5% (329), IgA 11.8% (151). Thirty-four monoclonal light chains (2.7%) were identified. Median concentration of monoclonal protein was 5.6 g/l (0.5-96.6). Most frequent diagnosis were: monoclonal gammopathy of undetermined significance or MGUS (77.6% in Blois and 64.1% in Rennes), multiple myeloma (11.9% and 12.7%), Waldenström's macroglobulinemia (4.4% and 8.7%).
CONCLUSION: Monoclonal gammopathy are common in clinical practice. MGUS account for more than 60% of monoclonal gammopathy. Given their frequency, diagnostic and follow-up strategies must be costless and simple.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566610     DOI: 10.1016/j.revmed.2007.04.011

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  Monoclonal gammopathies in a Moroccan military hospital.

Authors:  Z Ouzzif; K Doghmi; S Bouhsain; A Dami; S El Machtani; S Tellal; N Messaoudi; M Mikdame; A El Maataoui
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

2.  Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance.

Authors:  J M Piot; M Royer; A Schmidt-Tanguy; E Hoppé; M Gardembas; T Bourrée; M Hunault; S François; F Boyer; N Ifrah; G Renier; A Chevailler; M Audran; D Chappard; H Libouban; G Mabilleau; E Legrand; B Bouvard
Journal:  Blood Cancer J       Date:  2015-08-28       Impact factor: 11.037

3.  [Diagnostic and evolutionary profile of multiple myeloma in Senegal: monocentric study conducted from 2005 to 2016].

Authors:  Seynabou Fall; Fatma Dieng; Coumba Diouf; Boundia Djiba; Awa Cheikh Ndao; Fatou Samba Diago Ndiaye
Journal:  Pan Afr Med J       Date:  2017-08-08

4.  [Descriptive cross-sectional study assessing the clinical and paraclinic profiles of monoclonal gammopathies in an agricultural region of Souss-Massa, Morocco].

Authors:  Aissam El Maataoui; Aadil Taoufiq; Salma Fares; Kaouthar Sokori
Journal:  Pan Afr Med J       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.